Identification of Determinants of Interaction between CXCR4 and gp120 of a Dual-tropic HIV-1DH12Isolate  by Lee, Myung K. et al.
c
l
t
t
p
w
r
H
c
4
i
m
u
l
l
c
i
m
C
w
H
c
d
R
(
Virology 257, 290–296 (1999)
Article ID viro.1999.9686, available online at http://www.idealibrary.com on
0RAPID COMMUNICATION
Identification of Determinants of Interaction between CXCR4 and gp120
of a Dual-tropic HIV-1DH12 Isolate
Myung K. Lee, Jennifer Heaton, and Michael W. Cho1
Laboratory of Molecular Microbiology, NIAID, National Institutes of Health, Bethesda, Maryland 20892-0460
Received December 29, 1998; accepted March 2, 1999
Using a panel of chimeric viruses and their chimeric envelope glycoproteins, we have previously reported that the V1/V2
or the V3 regions of a dual-tropic primary human immunodeficiency virus type 1 (HIV-1) isolate (HIV-1DH12) could individually
confer CXCR4 usage when introduced into the backbone of a macrophage-tropic (M-tropic) virus isolate (HIV-1AD8). In this
study, chimeric CXCR4–CXCR2 chemokine receptors were employed to identify the determinants involved in the interaction
between CXCR4 and the dual-tropic HIV-1DH12 gp120. Our results indicate that (i) HIV-1DH12 gp120 interacts primarily with the
extracellular domains 1 (E1) and 2 (E2) of CXCR4, (ii) the V1/V2 and the V3 regions interact with different domains of CXCR4,
and (iii) the V1/V2 region plays a more critical role in the interaction between CXCR4 and HIV-1DH12 gp120. Combining our
data and those of others suggests that the pattern of CXCR4 usage is highly dependent on HIV-1 isolates. In addition, an
M-tropic virus may evolve to become dual-tropic by first acquiring the ability to interact with CXCR4 through the V1/V2 region
of gp120.r
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cHuman immunodeficiency virus type 1 (HIV-1) enters
ells through a series of interactions between its enve-
ope glycoprotein and cellular receptors. The binding of
he viral envelope to its primary receptor, CD4, is thought
o induce a conformational change in the surface glyco-
rotein, gp120 (42), which allows subsequent interaction
ith a variety of chemokine receptors (coreceptors; for
eviews, see 17, 21, 30, 32, 48). The cellular tropism of
IV-1 is determined primarily by which chemokine re-
eptor a particular virus strain utilizes (14, 19, 23, 24, 26,
7). Macrophage-tropic (M-tropic) strains that are able to
nfect macrophage, but not T-cell lines, utilize the b-che-
okine receptor CCR5. T-cell line tropic (T-tropic) strains
tilize the a-chemokine receptor CXCR4 and infect T-cell
ines, but not macrophages. Dual-tropic strains can uti-
ize both CCR5 and CXCR4 and are able to infect both
ell types. Regardless of cellular tropism, all viruses can
nfect primary T cells. Although a number of other che-
okine receptors have been identified (e.g., CCR2b,
CR3, GPR1, GPR15, STRL33, CCR8, APJ, and CX3CR1),
hich can function as a coreceptor for different strains of
IV-1 (13, 14, 16, 20, 23, 28, 40), their biological signifi-
ance in vivo is not yet clear.
Understanding how viral envelopes and their cellular
1 To whom correspondence and reprint requests should be ad-
ressed at Laboratory of Molecular Microbiology, NIH, NIAID, 9000
ockville Pike, Building 4, Room 339, Bethesda, MD 20892-0460. Fax:
301) 402-0226. E-mail: mcho@nih.gov.042-6822/99 290eceptors interact could contribute to the design of ef-
ective antiviral agents. Identifying the interacting deter-
inants between gp120 and coreceptors would facilitate
his process. Several previous studies have revealed the
mportance of the gp120 V3 region in determining cellular
ropism and coreceptor usage (8, 9, 14, 15, 18, 29, 33, 35,
3, 45, 47, 49). More recently we and others have dem-
nstrated that the V1/V2 region, in addition to the V3
egion, plays a critical role in coreceptor usage (10, 39,
4).
The availability of molecular clones of several chemo-
ine receptors from human and other species has facil-
tated the identification of receptor domains that interact
ith HIV-1 gp120. For example, studies with chimeric
CR5 constructs containing CCR2b (1, 2, 41) or mouse
CR5 (4, 34, 38) suggest that the interaction with gp120
s complex, involving multiple extracellular domains in a
ighly isolate-dependent manner. Furthermore, fusion
ediated by dual-tropic isolates is more sensitive to
lterations in CCR5 than is fusion mediated by M-tropic
solates (22, 34, 41). Although the interaction between
p120 and CXCR4 is also isolate-dependent, the CXCR4
nteracting determinants appear to vary less than CCR5
i.e., many HIV-1 (31) and HIV-2 (5, 37) strains preferen-
ially interact with the E3 domain of CXCR4). The E1
omain of CXCR4 is also utilized by some strains of HIV-2
5, 36) and HIV-1 (5, 31).
Using chimeric envelope glycoproteins, we have re-
ently reported that either the V1/V2 or the V3 region of
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291RAPID COMMUNICATIONdual-tropic HIV-1 isolate (HIV-1DH12) individually con-
erred the ability of an M-tropic HIV-1 isolate (HIV-1AD8) to
se CXCR4 (10). These results raised the possibility that
hese two variable gp120 regions interacted with differ-
nt extracellular domains of CXCR4. Using a set of chi-
eric envelope clones and CXCR4–CXCR2 chimeric che-
okine receptors (31) we examined the determinants of
nteraction between CXCR4 and a dual-tropic HIV-1DH12
p120 (Fig. 1).
We selected five chimeric chemokine receptors (i.e.,
444, 4442, 2442, 2244, and 2242) for this study based on
heir ability to be expressed on the cell surface and to
unction as coreceptors for HIV-1 gp120 (Fig. 1; (31)). A
ighly sensitive cell–cell fusion assay, utilizing a se-
reted alkaline phosphatase (SEAP)-chemiluminescence
etection system, was used to monitor the envelope–
oreceptor interaction. For this purpose, a plasmid en-
oding a SEAP gene under the control of T7 promoter
pTM-SEAP) was constructed by inserting a HindIII–ClaI
ragment from pSEAP-2-Basic (Clontech) into the NdeI–
amHI site of pTM–NdeI (12) subsequent to creating
lunt ends with Klenow fragment. pTM-SEAP and the
lasmids encoding chimeric envelope glycoproteins
pNVV-B, -C, -D, and -F) were used to construct recom-
inant vaccinia viruses (vTM-SEAP, vv120Benv,
v120Cenv, vv120Denv, and vv120Fenv, respectively) by
ethods described previously (12). To generate target
ells, plasmids encoding wild-type CCR5 (19), CXCR4,
XCR2, and CXCR4–CXCR2 chimeric coreceptors (31)
ere transfected into Mus dunni mouse fibroblast cells
clone III8C, ATCC) using lipofectin as described by the
anufacturer with minor modifications (Gibco BRL). After
h of incubation at 37°C, the transfected cells were
FIG. 1. Schematic diagram of chimeric envelopes and coreceptors. (
n this study. (Bottom) The parental (CXCR4 and CXCR2) and chime
ransferred from DH12 to AD8 and from CXCR4 to CXCR2, respectively
he junctions for the chimeric proteins, see Cho et al. (11) and Lu et aoinfected with vTF7-3 (27) and vCB-3 (7) encoding T7
olymerase and human CD4, respectively. To prepare
ffector cells expressing envelope, M. dunni cells were
oinfected with vTM-SEAP and one of the following vac-
inia viruses expressing HIV-1 envelope: vvADenv (AD8),
vDHenv (DH12), vv120Aenv (10); vv120B-D, -Fenv (this
tudy); vBD3 (89.6, (23)); vPE-16 (BH8 clone of IIIB, (25));
CB36, vCB28, and vCB43 (RF, JRFL, and Bal, respectively
6)). The cells were incubated at 37°C for 5 h, trypsinized,
nd washed, and duplicate samples containing 5 3 104
ach of target and effector cells were mixed in a 96-well
late in the presence of 80 mg/ml of cytosine arabinoside
Ara-C). The cells were incubated for 8 to 10 h at 37°C
nd the cell–cell fusion activity was monitored by mea-
uring SEAP activity in the culture supernatant using the
reat EscAPe SEAP chemiluminescence detection kit
Clontech).
The usage of chimeric coreceptors by the envelopes
f the two parental HIV-1 isolates (AD8 and DH12) was
irst compared to that of other HIV-1 strains (Fig. 2). As
xpected, the dual-tropic 89.6 gp160 efficiently used both
XCR4 and CCR5 while the T-tropic IIIB gp160 used
XCR4 only. As previously reported (31), these two en-
elopes were able to induce fusion with the 2242 chi-
era, albeit at low levels, indicating that the E3 domain
s involved in CXCR4–gp120 interaction (Fig. 2). In con-
rast to the results reported by Lu et al. (31), we observed
ugmented fusion activity with chimeras 2442 and 2444
ompared to 2242 for both 89.6 and IIIB envelopes,
uggesting an important contribution by the E2 domain
nd perhaps a synergy between the E2 and the E3
omains. The inclusion of the E1 domain to 2442 (i.e.,
442) significantly reduced the fusion activity for both of
e parental (DH12 and AD8) and chimeric (120A-D, F) envelopes used
mokine receptors. The variable regions and extracellular domains
dicated at the top of each panel. For the exact nucleotide position ofTop) Th
ric che
, are in
l. (31).
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292 RAPID COMMUNICATIONhese envelope glycoproteins, possibly due to structural
ncompatibility between the E1 domain of CXCR4 and the
4 domain of CXCR2. For example, the E1 region could
e interfering with the interaction between the E2/E3
omain and gp120 in the presence of the E4 domain of
XCR2.
HIV-1AD8 is a full-length infectious molecular clone of
n M-tropic HIV-1ADA (46). The virus is able to replicate in
eripheral blood mononuclear cells and monocyte-de-
ived macrophages, but not in T-cell lines (10). We and
thers (3, 4, 10, 14, 19, 23, 24, 34, 41) have previously
eported that HIV-1AD8 uses CCR5 but not CXCR4 for
irus entry. Unexpectedly, we detected, using our highly
ensitive assay, a low but significant (around 20% of
CR5) level of fusion activity with CXCR4 for AD8 (Fig. 2).
his is not an experimental artifact of our assay system
ince we were unable to detect any fusion with either Bal
Fig. 2) or JRFL (data not shown) gp160s, both of which
re M-tropic viruses. A similar level of fusion activity was
etected for the chimeric coreceptors 2242, strongly sug-
esting that the AD8 gp120 interacts with the E3 domain
f CXCR4. Interestingly, AD8 exhibited a pattern similar to
hat of IIIB and 89.6 in that the fusion activity with 4442
as lower than that with 2444 or 2442.
In contrast to IIIB, 89.6, and AD8, DH12 envelope
xhibited little or no fusion activity with 2242. Further-
ore, the fusion activity was higher for the chimeric
oreceptor 4442 than that of either 2444 or 2442. A
imilar pattern of chimeric coreceptor usage was ob-
erved for HIV-1 isolate RF (data not shown). These data
uggest that DH12 and RF gp120s interact differently
ith CXCR4 compared to IIIB, 89.6, and AD8 gp120s and
hat the E1 and E2 domains of CXCR4 are the primary
FIG. 2. Comparison of cell–cell fusion activity of HIV-1 envelopes.
hemokine receptors CCR5, CXCR4, and CXCR2 and the CXCR4–C
upernatant using the chemiluminescence detection method. Chemilum
Wallac). JRFL and RF exhibited patterns identical to those of Bal and DH
00% for all envelopes except for IIIB, for which CXCR4 was used.eterminants for interaction with DH12 and RF. This view
s consistent with the observation that the RF strain was
articularly sensitive to changes in the E1 domain (31).
lthough HIV-1RF has long been considered to be a
-tropic virus, we also found that RF could utilize both
XCR4 and CCR5 (data not shown) as previously re-
orted (31).
We have previously demonstrated that either the
1/V2 or the V3 region, but not the V4 or V5 region, of
IV-1DH12 gp120 allows HIV-1AD8 to use CXCR4 (10).
lthough HIV-1AD8 exhibited a low but detectable fusion
ctivity with CXCR4 using a more sensitive assay em-
loyed in this study, the completely different pattern of
himeric coreceptor usage compared to HIV-1DH12 al-
owed us to examine which variable regions of HIV-1DH12
p120 interacted with which extracellular domains of
XCR4. As shown in Fig. 3, the chimeric envelopes 120C
V4) and 120D (V5) exhibited a coreceptor usage pattern
lmost identical to that of the parental AD8 (e.g., low level
f CXCR4 usage, ability to utilize 2242, but not 4442). In
ontrast, the chimeric envelopes 120A (V1/V2), 120B (V3),
nd 120F (V1-3) were able to efficiently use parental
XCR4 as we have previously shown (10). Interestingly,
hile the chimeric envelopes 120A (V1/V2) and 120F
V1-3) exhibited a pattern identical to that of the parental
H12 gp120, 120B (V3) exhibited a hybrid phenotype: (i)
usion activity with 2242 (AD8 phenotype); (ii) good fusion
ctivity with 4442 (DH12 phenotype); and (iii) higher fu-
ion activity with 2444 and 2442 compared to 4442 (AD8
henotype). In fact, the general pattern looked very sim-
lar to that of 89.6 (Fig. 2). These results demonstrate that
he V1/V2 region of DH12 gp120 interacts with the E1 and
2 domains of CXCR4, the V1/V2 and the V3 regions
ll fusion activity of HIV-1 strains IIIB, 89.6, DH12, AD8, and Bal with
himera was monitored by measuring SEAP activity in the culture
ence was detected using a 1450 microbeta liquid scintillation counter
ectively (data not shown). The fusion activity for CCR5 was designatedCell–ce
XCR2 c
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293RAPID COMMUNICATIONnteract with CXCR4 differently, and the V1/V2 region
lays a more critical role than the V3 region in the
nteraction between CXCR4 and HIV-1DH12 gp120. The
himeric envelope 120B (V3), but not 120A (V1/V2), re-
ained the ability to utilize 2242, suggesting, although it
oes not prove, that the V1/V2 region of AD8 gp120 may
nteract with the E3 domain of CXCR4.
Although the use of chimeric proteins has led to an
nderstanding of the structural and functional properties
f many proteins, there are undoubtedly limitations that
rise simply because some combinations are structur-
lly incompatible and render the chimera nonfunctional.
lthough many more chimeric coreceptors were gener-
ted between CXCR4 and CXCR2 (31), we used only five
hat could be expressed well on the cell surface. Be-
ause some chimeric proteins may be only partially func-
ional, greater emphasis should be placed on the posi-
ive fusion activity rather than the negative results. In
ddition, what should be emphasized is how the overall
attern of chimeric coreceptor usage of one isolate com-
ares with that of other viruses. For example, while HIV-1
trains IIIB and 89.6 could utilize 2242, DH12 and RF
ould not (Fig. 2; and data not shown). Thus, it can be
oncluded that the E3 domain plays a more important
unction for IIIB and 89.6 than for DH12 or RF. While the
usion activity with 4442 was significantly lower than
444 or 2442 for IIIB and 89.6, the inverse was true for
H12 and RF, indicating that the E1 domain plays a
ritical role for the latter two strains (Fig. 2). Combining
he results from this and previously reported studies thus
ar, three general patterns emerge with respect to how
ifferent isolates of HIV-1 and HIV-2 envelopes interact
ith CXCR4: utilization of (i) the E2 and E3 domains (e.g.,
IV-1 IIIB and 89.6; (31) and this study); (ii) the E1 and E2
omains (e.g., HIV-1 DH12 and RF; (31) and this study);
nd (iii) the E1 and E3 domains (e.g., HIV-1 NDK and
IV-2 ROD; (5, 36, 37)).
We have employed a highly sensitive cell–cell fusion
FIG. 3. Relative cell–cell fusion activity of chimeric envelopes. Chime
ere tested for fusogenic activity against the chimeric CXCR4–CXC
nvelopes.ssay in this study. High sensitivity was achieved by
sing chemiluminescence detection of SEAP and using
ecombinant vaccinia viruses to express all of the com-
onents involved in fusion (except for the coreceptors),
hich is by far much more efficient than DNA transfec-
ion. The level of expression of the various components
n a cell–cell fusion assay is likely much greater than the
evel observed in vivo. Thus, although cell–cell fusion
ssay has been shown to correlate well with virus infec-
ivity assays in many previously reported studies and the
esults are biochemically valid, they should be inter-
reted with some caution. It is likely that the detection
imit of the fusion assay is much lower than that of the
irus infectivity assay in which case viral envelope–cel-
ular receptor interaction could be detected by the former
ut not the latter assay. Thus, it is not surprising to detect
low fusion activity of AD8 envelope with CXCR4 (Fig. 2)
lthough HIV-1AD8 could not infect the MT4 T-cell line
nd its infection of PBMC could be completely inhibited
y RANTES and MIP-1b (10). Our observation raises the
uestion of how to properly classify cellular tropism of
IV isolates. Cellular tropism should be determined by
hether or not a virus isolate can achieve an efficient
preading infection in biologically relevant cells. Core-
eptor usage analyses using a cell–cell fusion assay are
erformed to understand the complex biochemical inter-
ctions between viral envelope and cellular receptors.
hus, it may be more appropriate to classify HIV-1AD8 as
n M-tropic (R5) virus despite a low level of fusion activity
ith CXCR4.
The results in this study show that transfer of either the
1/V2 or the V3 regions of DH12 gp120 in the background
f AD8 envelope led to efficient utilization of CXCR4 by
D8 (Fig. 3). The results further suggest that the interac-
ion between V1/V2 and CXCR4 is more important than
hat between V3 and CXCR4 for the HIV-1DH12 envelope.
lthough the V3 region of gp120 has recently been
hown to play a critical role for strictly T-tropic HIV-1
elopes 120A (V1/V2), 120B (V3), 120C (V4), 120D (V5), and 120F (V1-3)
ceptors. The fusion activity for CCR5 was designated 100% for allric env
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294 RAPID COMMUNICATIONsolates in determining cellular tropism and CXCR4 us-
ge (45), it is possible that the V1/V2 region may play a
ore important function for dual-tropic isolates. In this
egard, it is interesting to note that Smyth et al. (44) have
eported that the regions outside of the V3-5 (presumably
he V1/V2 region) determine CXCR4 utilization for HIV-189.6.
urthermore, a B-cell epitope of a highly potent neutral-
zing antibody elicited in a chimpanzee infected with
IV-1DH12 consists of parts of V1/V2, but not the V3
egion (manuscript in preparation).
Dual-tropic viruses may represent evolutionary inter-
ediates between M-tropic and T-tropic isolates during
he course of AIDS pathogenesis in vivo. It has been
roposed that dual-tropic viruses evolve from M-tropic
solates by acquiring the ability to use CXCR4 while
etaining the ability to interact with CCR5 (31). It is pos-
ible that the HIV-1AD8 isolate may represent an early
ariant of an M-tropic virus that has just acquired the
bility to use CXCR4. The fusion activity with 2242 was
omparable with that of CXCR4, suggesting that AD8
tilizes primarily the E3 domain (Fig. 2). Replacement of
he V1/V2 region of AD8 gp120 with that of DH12 (120A),
ut not the V3 region (120B), eliminated the ability of the
himeric envelope to utilize 2242, suggesting that the
1/V2 region of AD8 gp120 might interact with the E3
omain of CXCR4. Since the V1/V2 region seems to play
crucial role in utilizing CXCR4 for the dual-tropic HIV-1
solates examined thus far (i.e., DH12 and 89.6 (44)), one
ould speculate that M-tropic viruses initially become
ual-tropic by acquiring the ability to interact with CXCR4
hrough its V1/V2 region while the V3 region maintains its
bility to utilize CCR5. The V1/V2 region may interact with
ither the E1 (e.g., DH12 and RF) or the E3 (e.g., 89.6)
omains of CXCR4. Subsequently, the V3 region of gp120
ould accumulate mutations that could strengthen the
nteraction between viral envelope and CXCR4. Alterna-
ively, the V1/V2 region, the V3 region, or both regions
ould coevolve in a nonsequential manner that gradually
lters the coreceptor usage pattern of an M-tropic virus
o that of a T-tropic virus. Clearly, there have not been
nough studies on identification of determinants of in-
eraction for dual-tropic viruses to definitively state one
ay or the other. Future studies using chimeric enve-
opes generated between AD8 and strictly CCR5 utilizing
nvelopes (e.g., Bal or JRFL) may provide better under-
tanding of viral evolution with respect to cellular tropism
nd coreceptor usage.
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